Alkaloid and benzopyran compounds of Melicope latifolia fruit exhibit anti-hepatitis C virus activities

نویسندگان

چکیده

Abstract Background New agents for developing alternative or complementary medicine to treat the hepatitis C virus (HCV) are still needed due high rates of HCV infection globally and current limitations available treatments. Treatment with a combination direct acting antivirals have been shown be approximately 90% effective but will limited in future emergence drug resistance cost. The leaves Melicope latifolia previously reported anti-HCV activity potential source bioactive compounds novel development. This study aimed evaluate efficacy extract M. fruit isolate its active compounds. Method was extracted using methanol purified vacuum liquid chromatography (VLC) Radial Chromatography. analyzed cell culture lines Huh7it-1 JFH1 (genotype 2a). Time-of-addition immunoblotting studies were performed identify mode action isolated structures determined nuclear magnetic resonance (NMR) spectra, UV, IR, Mass Spectra. Results Six known from fruit: O-methyloktadrenolon, alloevodionol, isopimpinellin, alloxanthoxyletin, methylevodionol, N-methylflindersine. N-methylflidersine most compound IC 50 value 3.8 ?g/ml while alloevodionol less active. O-methyloktadrenolon alloxanthoxyletin moderately values 10.9 21.72 ?g/ml, respectively. decreased level NS3 protein expression cells. Conclusion alkaloid compound, N-methylflindersine which possesses through post-entry inhibition suppressed expression.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hepatitis C virus and skin

Nowadays viral hepatitis is one of the most common and important causes of chronic liver disorders in the world. Extrahepatic manifestations of viral hepatitis consist a main part of the disease. The main viruses causing hepatitis include Hepatitis A, B and C viruses. Herein common skin manifestations in hepatitis C virus (HCV) are discussed. Chronic hepatitis causes skin disorders both directl...

متن کامل

Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds.

Therapy for hepatitis C virus (HCV) infection has advanced with the recent approval of direct-acting antivirals in combination with peginterferon and ribavirin. New antivirals with novel targets are still needed to further improve the treatment of hepatitis C. Previously reported screening methods for HCV inhibitors either are limited to a virus-specific function or apply a screening method at ...

متن کامل

Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...

متن کامل

Anti-hepatitis C virus drugs and kidney

Hepatitis C virus (HCV) mainly targets the liver but can also induce extrahepatic manifestations. The kidney may be impacted via an immune mediated mechanism or a cytopathic effect. HCV patients are clearly at a greater risk of chronic kidney disease (CKD) than uninfected patients are, and the presence of CKD increases mortality. Interferon-based therapies and ribavirin are difficult to manage ...

متن کامل

Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects.

Polysaccharides were extracted from fruiting bodies and cultured mycelia from five Antrodia camphorata strains. Polysaccharide profiles of the five strains, as determined by high-performance anion-exchange chromatography, showed varying yields and composition of neutral sugars. A. camphorata fruiting bodies also had different polysaccharide patterns compared to the cultured mycelium. Analysis o...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMC complementary medicine and therapies

سال: 2021

ISSN: ['2662-7671']

DOI: https://doi.org/10.1186/s12906-021-03202-8